FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3095226980> ?p ?o ?g. }

• W3095226980 endingPage "798" @default.
• W3095226980 startingPage "797.1" @default.
• W3095226980 abstract "Background: Current pharmacotherapies to treat or prevent hand osteoarthritis are limited. Colchicine, an anti-inflammatory agent effective at reducing joint pain and swelling in gouty arthritis, may offer relief in hand osteoarthritis, though this has not been investigated before. 1 Objectives: To investigate the efficacy of colchicine compared to placebo on VAS pain scores over 12 weeks in adults with hand osteoarthritis in a randomised, double-blind controlled trial. Methods: 64 community-dwelling adults with hand osteoarthritis (American College of Rheumatology criteria) 2 (54 females, 48-79 years) were randomised 1:1 to colchicine (0.5mg twice daily) or placebo for 12 weeks. VAS pain scores (worst affected hand) were obtained at baseline and weeks 6, 12, and after treatment withdrawal at week 16. Secondary outcome measures included grip strength, C-reactive protein (CRP) and tender and swollen joint count (TSJC). Grip strength, TSJC and CRP were obtained at baseline and week 12. Intention-to-treat analyses, adjusted for age and gender, were performed using constrained longitudinal data analysis models in Stata v16. 3 This study is registered with the Australia New Zealand Clinical Trials Registry, ACTRN12617001524381. Results: 58 participants completed the study (N=27 colchicine, N=31 placebo, withdrawal rate 9%). Mean (S.D) VAS score of the affected hand at baseline was 71.4 (14.5) mm in the placebo and 65.4 (15.0) mm in the colchicine group (p = 0.11). VAS scores improved during treatment, but were comparable between groups at week 6, 12 and 16 (Table 1). There were no differences between groups at week 12 for CRP, TSJC or grip strength (Table 1). Adverse events related to study medications included nausea (n=4), diarrhoea (n=9), vomiting (n=3), bloating (n=1) and reflux (n=1). Table 1. COLAH study primary and secondary outcomes, from constrained longitudinal data analysis model Outcome Timepoint Colchicine (SE) Placebo (SE) Colchicine-Placebo (95% CI) p-value VAS Pain (mm) 6 weeks 53.5 (4.5) 53.9 (4.6) -0.4 (-12.3, 13.1) 0.95 12 weeks 57.1 (4.4) 48.4 (4.6) 8.7 (-21.2, 3.9) 0.18 16 weeks 62.0 (4.3) 61.6 (3.7) -0.4 (-11.4, 10.5) 0.94 TSJC (0-20) 12 weeks 5.6 (0.7) 3.8 (0.7) 1.8 (-4.1, 0.5) 0.13 Grip strength (kg) 12 weeks 14.4 (0.8) 15.3 (0.8) -0.9 (-0.2, 2.0) 0.10 CRP (mg/L) 12 weeks 4.5 (1.4) 4.0 (1.3) 0.5 (-3.8, 2.9) 0.77 Conclusion: Colchicine 1mg daily for 12 weeks was not effective in improving pain, tender and swollen joint count or grip strength in symptomatic hand osteoarthritis patients. This study does not support colchicine for treatment of symptoms of hand osteoarthritis. References: [1]Leung, YY, Hui, LLY, Kraus, VB 2015. Colchicine-Update on mechanisms of action and therapeutic uses. Seminars in Arthritis and Rheumatism ; 45: 341-350. [2]Altman, R, Alarcon, G, Appelrouth, D et al, 1990. American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheumatology; 33(11): 1601-10. [3]Liu GF, Lu K, Mogg R, et al. 2009. Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials? Stat Med ; 28: 2509–30. Characters from table content including title and footnotes: 465 Disclosure of Interests: None declared" @default.
• W3095226980 created "2020-11-09" @default.
• W3095226980 creator A5001032009 @default.
• W3095226980 creator A5034122152 @default.
• W3095226980 creator A5035631448 @default.
• W3095226980 creator A5035957373 @default.
• W3095226980 creator A5065283550 @default.
• W3095226980 creator A5073888102 @default.
• W3095226980 creator A5079360598 @default.
• W3095226980 creator A5087343316 @default.
• W3095226980 date "2020-06-01" @default.
• W3095226980 modified "2023-10-14" @default.
• W3095226980 title "FRI0399 COLCHICINE IS NOT EFFECTIVE FOR REDUCING OSTEOARTHRITIC HAND PAIN COMPARED TO PLACEBO: A RANDOMISED, PLACEBO-CONTROLLED TRIAL (COLAH)" @default.
• W3095226980 doi "https://doi.org/10.1136/annrheumdis-2020-eular.4040" @default.
• W3095226980 hasPublicationYear "2020" @default.
• W3095226980 type Work @default.
• W3095226980 sameAs 3095226980 @default.
• W3095226980 citedByCount "1" @default.
• W3095226980 countsByYear W30952269802021 @default.
• W3095226980 crossrefType "journal-article" @default.
• W3095226980 hasAuthorship W3095226980A5001032009 @default.
• W3095226980 hasAuthorship W3095226980A5034122152 @default.
• W3095226980 hasAuthorship W3095226980A5035631448 @default.
• W3095226980 hasAuthorship W3095226980A5035957373 @default.
• W3095226980 hasAuthorship W3095226980A5065283550 @default.
• W3095226980 hasAuthorship W3095226980A5073888102 @default.
• W3095226980 hasAuthorship W3095226980A5079360598 @default.
• W3095226980 hasAuthorship W3095226980A5087343316 @default.
• W3095226980 hasBestOaLocation W30952269801 @default.
• W3095226980 hasConcept C126322002 @default.
• W3095226980 hasConcept C141071460 @default.
• W3095226980 hasConcept C142724271 @default.
• W3095226980 hasConcept C168563851 @default.
• W3095226980 hasConcept C1862650 @default.
• W3095226980 hasConcept C198451711 @default.
• W3095226980 hasConcept C204787440 @default.
• W3095226980 hasConcept C27081682 @default.
• W3095226980 hasConcept C2776164576 @default.
• W3095226980 hasConcept C2776636253 @default.
• W3095226980 hasConcept C2777077863 @default.
• W3095226980 hasConcept C2777433710 @default.
• W3095226980 hasConcept C2780402116 @default.
• W3095226980 hasConcept C71924100 @default.
• W3095226980 hasConceptScore W3095226980C126322002 @default.
• W3095226980 hasConceptScore W3095226980C141071460 @default.
• W3095226980 hasConceptScore W3095226980C142724271 @default.
• W3095226980 hasConceptScore W3095226980C168563851 @default.
• W3095226980 hasConceptScore W3095226980C1862650 @default.
• W3095226980 hasConceptScore W3095226980C198451711 @default.
• W3095226980 hasConceptScore W3095226980C204787440 @default.
• W3095226980 hasConceptScore W3095226980C27081682 @default.
• W3095226980 hasConceptScore W3095226980C2776164576 @default.
• W3095226980 hasConceptScore W3095226980C2776636253 @default.
• W3095226980 hasConceptScore W3095226980C2777077863 @default.
• W3095226980 hasConceptScore W3095226980C2777433710 @default.
• W3095226980 hasConceptScore W3095226980C2780402116 @default.
• W3095226980 hasConceptScore W3095226980C71924100 @default.
• W3095226980 hasIssue "Suppl 1" @default.
• W3095226980 hasLocation W30952269801 @default.
• W3095226980 hasOpenAccess W3095226980 @default.
• W3095226980 hasPrimaryLocation W30952269801 @default.
• W3095226980 hasRelatedWork W1581445871 @default.
• W3095226980 hasRelatedWork W1980329869 @default.
• W3095226980 hasRelatedWork W2002353766 @default.
• W3095226980 hasRelatedWork W2044504338 @default.
• W3095226980 hasRelatedWork W2054857075 @default.
• W3095226980 hasRelatedWork W2406206830 @default.
• W3095226980 hasRelatedWork W2410322962 @default.
• W3095226980 hasRelatedWork W3095226980 @default.
• W3095226980 hasRelatedWork W3109024239 @default.
• W3095226980 hasRelatedWork W3169075200 @default.
• W3095226980 hasVolume "79" @default.
• W3095226980 isParatext "false" @default.
• W3095226980 isRetracted "false" @default.
• W3095226980 magId "3095226980" @default.
• W3095226980 workType "article" @default.